- $12.22m
- $38.24m
- $1.02m
Brief: Pluristem Therapeutics Says Co Entered Into Open Market Sale Agreement With Jefferies
U.S. STOCKS ON THE MOVE-Whiting Petroleum, Medigus, Pluristem Therapeutics
Pluristem: Surges after securing 50 mln euros to develop COVID-19 treatment
Israel to weigh "compassionate use" of Pluristem therapy for COVID-19
Pluristem gets positive results from radiation treatment trials
Brief: Pluristem Announces One-For-Ten Reverse Split Of Its Common Shares
Brief: Pluristem, U.S. DoD To Announce Data From Studies Testing Plx-R18 As Prophylactic Treatment For Acute Radiation Syndrome
Brief: Pluristem Approved Reduction Of CEO Salary, Compensation Paid To Executive Chairman, Annual Fees Paid To Directors
Brief: Pluristem Therapeutics Inc - Expect Interim Data Readout From Plx-Pad For Critical Limb Ischemia In First Half Of 2020
Brief: Pluristem Says Yaky Yanay Appointed As Chief Executive Officer
Brief: Pluristem Says Co Has Developed Serum-Free Formulation To Support Manufacturing Of Cell Therapy Products
Brief: Pluristem Files Patent Application For The Use Of Its Advanced Manufacturing Technology In The Cannabis Industry
Brief: Pluristem Says Recent Financing Attracted Long-Term Oriented Institutional Investors
Brief: Pluristem Therapeutics Says Got Notice That Co's Closing Bid Price Was Below $1.00/Share For Last 30 Consecutive Business Days
U.S. STOCKS ON THE MOVE-Tesla, Boeing, Facebook, Shopify, Micron, Office Depot
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Facebook, Constellation Brands, Office Depot
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Facebook, Office Depot
Pluristem: Plunges to record low on $20 mln equity raise
Brief: Pluristem Therapeutics Announces Pricing Of Its Public Offering And Registered Direct Offering For Aggregate Proceeds Of Approximately $20 Mln